Author Archives: donttradeourlivesaway

TRIPping Up Least Developed Countries on Medicines, Green Tech, and Textbooks?

Posted on May 21, 2013

Source: Foreign Policy in Focus May 20,2013 As Brazilian Ambassador Roberto Azevedo won the race to head the World Trade Organization (WTO) last week, he must have been at least a little worried about taking over an organization that even leading … Continue reading →

Posted in access to medicines, EU-India FTA, FDI, FTAs, IP Rights, LDCs, patent, TRIPS, WTO | Tagged , , , , , | Leave a comment

Live from the Trans Pacific Partnership: IP Chapter Shows No Sign of Resolution, End of Negotiation in 2013 Highly Unlikely

Posted on May 21, 2013

Source: Infojustice May 20,2013 LIMA – There is a strong sense in the halls of the current TPP negotiation that the end is not in sight. And one of the primary reasons for the blocked progress is a lack of … Continue reading →

Posted in ACTA, IP Rights, TPPA, Trans-Pacific Partnership Agreement, TRIPS, WTO | Tagged , , , , , | Leave a comment

TRIPS Exemption Opposed By Obama Administration, Threatening Cost Spike For Drugs In Poorest Nations

Posted on May 21, 2013

Source: Huffington Post May20,2013 WASHINGTON — The Obama administration is seeking to curb efforts to exempt the world’s poorest countries from expansive trade rules that would substantially increase the price of life-saving medicine and other products. The regulations would extend … Continue reading →

Posted in access to medicines, Drug Pricing, IP Rights, LDCs, patent, TRIPS, WTO | Tagged , , , | Leave a comment

Open Letter to TRIPS Council Chairman on LDC Extension: Alfredo Suescum, Ambassador of Panama to the World Trade Organization (WTO)

Posted on May 21, 2013

Source: KEI May 20, 2013 Dear Ambassador Suescum, We are outraged with the manner in which informal consultations are being conducted on the issue of extension of the LDC¹s transition period. We find the current process to be unfair and … Continue reading →

Posted in IP Rights, LDC transition period, LDCs, TRIPS, WTO | Tagged , , , | Leave a comment

Trans Pacific Partnership Negotiations and the Controversial Issue of Pharmaceutical Test Data Protection

Posted on May 21, 2013

Source: Infojustice May 17,2013 Trade negotiators are meeting in Lima, Peru this week for the seventeenth round of talks on the proposed Trans Pacific Partnership (TPP).  The negotiations are reaching the final stages as an October deadline approaches, and the … Continue reading →

Posted in access to medicines, data exclusivity, IP Rights, patent, TPPA, Trans-Pacific Partnership Agreement, TRIPS, WTO | Leave a comment

India-EU FTA talks fail to bridge gaps; ministerial meet unlikely

Posted on May 21, 2013

Source: Zee News May 17,2013 New Delhi: In a set back to talks for the long-pending India-EU FTA, the chief negotiators’ meet on Friday failed to bridge “substantial gaps” on crucial issues, including insurance and data security status for IT … Continue reading →

Posted in EU-India FTA, FDI, Generic drug, IP Rights, patent, TRIPS, WTO | Tagged , , , | Leave a comment

A victory for global public health in the Indian, Ellen T Hoen

Posted on May 21, 2013

Source: Journal of Public Health Policy Abstract On 1 April of this year, the Indian Supreme Court upheld the decision of the Indian Patent Office to refuse the patent grant for Novartis imatinib mesylate (Gleevec). The patent application failed to meet the … Continue reading →

Posted in access to medicines, Generic drug, IP Rights, Novartis Case, patent, Sec 3 (d) | Tagged , , , | Leave a comment

India-EU FTA: Top officials hold second round of talks

Posted on May 17, 2013

Source: Economic Times 16th May,2013 NEW DELHI: Chief negotiators of India and the EU today held the second round of talks on the stalled free trade agreement on which the discussions had started in June 2007. Although the technical level … Continue reading →

Posted in EU-India FTA, FDI, IP Rights, TRIPS, WTO | Leave a comment

India: Patents and precedents

Posted on May 16, 2013

Source:Financial Times May 15,2013 Pharmaceutical companies fear that the battle raging in India over patents will inspire other countries to change their laws

Posted in access to medicines, Drug Pricing, Generic drug, IP Rights, Novartis Case, patent, Sec 3 (d) | Tagged , , , , | Leave a comment

Court ruling over privileged access for business in EU-India free trade talks

Posted on May 16, 2013

Source: Corporate Europe May15, 2013 Judgment to be delivered in Luxembourg The EU’s General Court has announced a date for the judgement in Corporate Europe Observatory’s legal action, suing the European Commission for withholding information related to the EU’s free … Continue reading →

Posted in EU-India FTA, IP Rights, TRIPS, WTO | Tagged , , , , , , , | Leave a comment